Authors
Loading...
Combination treatment with NCX 4040 and Napabucasin reduces cell viability and migratory abilities in metastatic prostate cancer, suggesting potential as a therapeutic strategy.
Pathak et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: